Epidemiology, biology and therapy of Merkel cell carcinoma: conclusions from the EU project IMMOMEC

Juergen C. Becker, Andreas Stang, Axel zur Hausen, Nicole Fischer, James A. DeCaprio, Richard W. Tothill, Rikke Lyngaa, Ulla Kring Hansen, Cathrin Ritter, Paul Nghiem, Christopher K. Bichakjian, Selma Ugurel, David Schrama

Research output: Contribution to journalReview articleAcademicpeer-review

Original languageEnglish
Pages (from-to)341-351
Number of pages11
JournalCancer Immunology Immunotherapy
Volume67
Issue number3
DOIs
Publication statusPublished - 1 Mar 2018

Keywords

  • Merkel cell carcinoma
  • Epidemiology
  • Cell of origin
  • Merkel cell polyomavirus
  • Immunotherapy
  • IMMOMEC
  • SMALL T-ANTIGEN
  • DOWN-REGULATION
  • POLYOMAVIRUS
  • EXPRESSION
  • RECURRENCE
  • GROWTH
  • PROLIFERATION
  • INHIBITION
  • PREVALENT
  • SURVIVAL

Cite this

Becker, J. C., Stang, A., zur Hausen, A., Fischer, N., DeCaprio, J. A., Tothill, R. W., Lyngaa, R., Hansen, U. K., Ritter, C., Nghiem, P., Bichakjian, C. K., Ugurel, S., & Schrama, D. (2018). Epidemiology, biology and therapy of Merkel cell carcinoma: conclusions from the EU project IMMOMEC. Cancer Immunology Immunotherapy, 67(3), 341-351. https://doi.org/10.1007/s00262-017-2099-3